By Staff
Wednesday, April 3, 2019 12:15 AM
BETHESDA, Md.—
RightEye announced that it has built an extensive database that is being used by major research and health institutions to examine the eye-brain connection and detect the early onset of neurological conditions such as Parkinson’s Disease. The database was built using more than one billion data points from over 100,000 patient tests conducted with RightEye’s eye-tracking system. The anonymized data, which RightEye expects to exceed two billion data points by year end, is providing researchers with a new and deeper understanding of early indicators for neurological issues, which are anticipated to help in the development of new treatment options and interventions, the company said.
By Staff
Tuesday, April 2, 2019 9:00 AM
BETHESDA, Md.—
RightEye announced that it has built an extensive database that is being used by major research and health institutions to examine the eye-brain connection and detect the early onset of neurological conditions such as Parkinson’s Disease. The database was built using more than one billion data points from over 100,000 patient tests conducted with RightEye’s eye-tracking system. The anonymized data, which RightEye expects to exceed two billion data points by year end, is providing researchers with a new and deeper understanding of early indicators for neurological issues, which are anticipated to help in the development of new treatment options and interventions, the company said.
By Staff
Tuesday, April 2, 2019 12:24 AM
LONDON—
Clearly, a global charity tackling the issue of poor vision has highlighted the dramatic rise of myopia among children around the world, with figures set to increase from an already worrying 300 million children today to 500 million by 2050. The revised data was featured at the start of
Sightgeist a one-day event held here set up by Clearly founder James Chen on March 28, uniting many stakeholders and organizations working to address unmet vision care access around the world.
By Staff
Tuesday, March 19, 2019 12:30 AM
FORT WORTH, Texas—
Alcon, a global leader in eyecare, said Monday it has acquired
PowerVision Inc., a privately-held, U.S.-based medical device development company focused on creating fluid-based intraocular lens implants. Alcon said the acquisition furthers its commitment to drive growth and innovation in advanced technology intraocular lenses (AT-IOLS) to meet the needs of cataract surgery patients who desire spectacle independence. “As the industry leader in cataract surgery, we’re eager to accelerate development of this potentially breakthrough accommodating lens technology,” said Alcon’s Michael Onuscheck, president of global business and innovation.
By Staff
Wednesday, February 20, 2019 12:15 AM
SACRAMENTO, Calif.—A recent California Health Policy Strategies
policy brief finds that the partnership between the
California Optometric Association (COA), Anthem Blue Cross Medi-Cal Health Plan, and community health centers throughout California was successful in connecting diabetes patients with comprehensive care. In this partnership, Anthem Blue Cross Medi-Cal Health Plan reached out to its members with a history of diabetes who had not accessed recommended health screenings, and invited them to the Diabetes Day Clinic at a local health center.
By Staff
Tuesday, February 12, 2019 12:15 AM
RARITAN, N.J.—The
Janssen unit of
Johnson & Johnson has announced a worldwide collaboration and license agreement with
MeiraGTx Holdings (NASDAQ:MGTX), a clinical-stage gene therapy company, to develop, manufacture and commercialize its clinical stage inherited retinal disease portfolio. The portfolio includes leading product candidates for achromatopsia (ACHM) caused by mutations in either CNGB3 or CNGA3, and X-linked retinitis pigmentosa (XLRP). Further, the companies have formed a research collaboration to explore new targets for other inherited retinal diseases and further develop adeno-associated virus (AAV) manufacturing technology, according to an announcement.
By Andrew Karp
Monday, January 21, 2019 12:30 AM
As recently as a decade ago, a mention of digital eye strain (DES) would have most people scratching their heads. Today it’s ubiquitous, a condition of modern life. From toddlers to millennials to seniors, from city dwellers to shepherds in remote mountain villages, no one is immune from DES and its effects, which include dry, irritated eyes, blurred vision and assorted aches and pains. More than half of American adults suffer adverse effects from overexposure to screens, according to The Vision Council, which coined the term digital eye strain.
By Andrew Karp
Monday, January 21, 2019 12:29 AM
As knowledge and awareness of digital eye strain has increased, so too have the number of solutions for alleviating its symptoms. Solutions range from behavioral—reducing screen time, adjusting work spaces, work habits and screen brightness—to a growing range of products designed to prevent or alleviate DES symptoms.
By Andrew Karp
Monday, January 21, 2019 12:28 AM
As part of its ongoing efforts to raise public awareness of digital eyestrain, The Vision Council conducted a media campaign in 2018 in conjunction with Health Vision Month in May. The Vision Council teamed up with actress, journalist, podcaster and TV host Maria Menounos—best known for her correspondence on “E! News”—for a sponsored Instagram post promoting the importance of wearing glasses outfitted with specialized lenses to protect the eyes from digital devices, highlighting product from Eyewear & Accessories (E&A) Division member Marchon Eyewear. Menounos reaches 971,000 followers on Instagram, and her post has received nearly 14,000 likes.
By Andrew Karp
Monday, January 21, 2019 12:27 AM
Many vision researchers believe there is growing evidence that digital screen use is a contributing factor to the spread of myopia worldwide. For example, Essilor USA’s website, Myopiaexperts (https://www.essilorusa.com/myopiaexperts#/), points out that myopia tends to progress during childhood, as the eyes continue to grow and develop.
By Andrew Karp
Monday, January 21, 2019 12:26 AM
Exposure to blue light between 410 and 450 nm contributes to digital eye strain. Vision Monday has compiled an online resource that consists of descriptions of 48 different products that offer blue light management solutions for every situation, both indoors and outdoors.
By Staff
Tuesday, January 15, 2019 12:18 AM
PALO ALTO, Calif.—
SightGlass Vision, Inc. has announced that CYPRESS, a clinical trial to control nearsightedness in children, is now enrolling patients in the U.S. and Canada. This CYPRESS study will evaluate the safety and efficacy of SightGlass Vision’s novel lenses compared to standard lenses to reduce the rate of progression of myopia in children between the ages of six and nine over the course of 36 months. The multicenter, double-blinded, randomized controlled trial will enroll 255 patients across 14 sites in the U.S. and Canada. SightGlass expects to complete trial enrollment by the end of Q1 2019, and to report their initial results in 2020, which will later be accompanied by additional data after a longer-term follow up.
By Staff
Friday, January 4, 2019 12:15 AM
BALTIMORE—A national employee benefits provider finds that cutting vision health insurance benefits may prompt up to one-third of working Millennials to look for a new job. According to an online survey conducted by Unum of more than 1,200 people working in the U.S., 34 percent of people aged 25 to 34 consider vision insurance to be a key factor when choosing (or leaving) an employer.
By Staff
Tuesday, December 11, 2018 12:15 AM
CHARENTON-LE-PONT, France—
Essilor commits to further expanding its unique inclusive business and philanthropic programs to eradicate unprotected and uncorrected poor vision in the
Kingdom of Bhutan, where 25 percent of the population suffer from uncorrected refractive errors and much of the population is at risk of exposure to UVA/UVB rays due to high altitude. Last week, the Essilor Group signed letters of intent with the Royal Government of Bhutan and the Central Monastic Body to sustainably strengthen the country’s vision care infrastructure.
By Staff
Wednesday, November 14, 2018 12:15 AM
CHICAGO—
Prevent Blindness is seeking nominations for the
2019 Jenny Pomeroy Award for Excellence in Vision and Public Health. The award will recognize an individual, team, or organization that has made an outstanding contribution to the field of public health, as well as to vision and eye health worldwide, according to a release from Prevent Blindness. The deadline for submissions is Dec.13, 2018. President and CEO of Prevent Blindness, Jeff Todd, said “Promoting new and innovative approaches to vision and eye health challenges is essential to our mission of preventing blindness and preserving sight.